Risk assessment in haematopoietic stem cell transplantation: Viral status

被引：30
|
作者：
Ljungman, Per [1 ]
机构：
[1] Karolinska Inst, Karolinska Univ Hosp, Hematol Ctr, SE-14186 Stockholm, Sweden
来源：
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY | 2007年 / 20卷 / 02期
关键词：
viral infections; serology; CMV; stem-cell transplantation; donors;
D O I：
10.1016/j.beha.2006.09.003
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Viral infections have been important complications in the transplant procedure from the early days of stem-cell transplantation, causing significant morbidity and mortality. It is important for the management of patients to assess the risk for viral infections that might develop after the stem-cell transplantation. This can be exemplified by cytomegalovirus (CMV) and other herpesviruses, but risk assessment is also important for other viral infections. The aim of this review is to describe current knowledge regarding recipient and donor serological status for viral infections.
引用
收藏
页码：209 / 217
页数：9
相关论文
共 50 条
  • [31] Adoptive T Cell Therapy Strategies for Viral Infections in Patients Receiving Haematopoietic Stem Cell Transplantation
    Ottaviano, Giorgio
    Chiesa, Robert
    Feuchtinger, Tobias
    Vickers, Mark A.
    Dickinson, Anne
    Gennery, Andrew R.
    Veys, Paul
    Todryk, Stephen
    CELLS, 2019, 8 (01)
  • [32] Risk factors of CMV reactivation post allogeneic haematopoietic stem cell transplantation
    Jaskula, E.
    Drabczak-Skrzypek, D.
    Mlynarczewska, A.
    Sedzimirska, M.
    Bogunia-Kubik, K.
    Lange, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S267 - S267
  • [33] Allogeneic or autologous haematopoietic stem cell transplantation for non-Hodgkin lymphoma: status at transplantation and outcome
    Ferrant, A
    Van den Neste, E
    Michaux, L
    Durbecq, J
    Latinne, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S36 - S36
  • [34] Haemolysis as an indepent risk factor for outcome after haematopoietic stem cell transplantation?
    Stussi, G
    Halter, J
    Hutter, A
    Gratwohl, A
    Passweg, JR
    Seebach, JD
    BONE MARROW TRANSPLANTATION, 2006, 37 : S85 - S85
  • [35] Disease relapse after haematopoietic stem cell transplantation: Risk factors and treatment
    Dazzi, F.
    Fozza, C.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (02) : 311 - 327
  • [36] Allogeneic Haematopoietic Stem Cell Transplantation - An Overview
    Holtick, U.
    Chemnitz, J. M.
    Hallek, M.
    Scheid, C.
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2015, 232 (05) : 641 - 646
  • [37] Paediatric haematopoietic stem cell transplantation in Iran
    Ghavamzadeh, A.
    Hamidieh, A. A.
    Jahani, M.
    Alimoghaddam, K.
    Mousavi, A.
    Iravani, M.
    Bahar, B.
    Khodabandeh, A.
    Nedaiefard, L.
    Ashouri, A.
    Basirpanah, S.
    Mousavi, A.
    Shahriari, Z.
    Khalilvand, S.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S294 - S294
  • [38] BAFF LEVELS IN HAEMATOPOIETIC STEM CELL TRANSPLANTATION
    Yanez, L.
    Yanez, L.
    Castaneda, M.
    Pena, M.
    Bermudez, A.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 326 - 326
  • [39] Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis
    Horne, A
    Janka, G
    Egeler, RM
    Gadner, H
    Imashuku, S
    Ladisch, S
    Locatelli, F
    Montgomery, SM
    Webb, D
    Winiarski, J
    Filipovich, AH
    Henter, JI
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 622 - 630
  • [40] The thymus in allogeneic haematopoietic stem cell transplantation
    Choufi, Bachra
    Lassoued, Kaiss
    HEMATOLOGIE, 2012, 18 (05): : 272 - 282
12345